Collectively, our findings reveal that UBE2S inhibited PTEN, leaded to the activation of AKT pathway, protected HCC cells from the cytotoxic effect of chemotherapy agents, implicating a novel role of UBE2S in the regulation of cell chemoresistance. Here, AKT1 is linked to hepatocellular carcinoma.